[1] Kruger R, Kuhn W, Muller T,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in parkinson's disease[J]. Nat Genet, 1998, 18(2):106-108. [2] International Parkinson Disease Genomics Consortium, Nalls M A, Plagnol V, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease:a meta-analysis of genome-wide association studies[J]. Lancet, 2011, 377(9766):641-649. [3] Polymeropoulos M H, Lavedan C, Leroy E, et al.Mutation in the alpha-synuclein gene identified in families with Parkinson's disease[J]. Science, 1997, 276(5321):2045-2047. [4] Rodriguez-Araujo G, Nakagami H, Takami Y, et al.Low alpha-synuclein levels in the blood are associated with insulin resistance[J]. Sci Rep, 2015, 5:12081. [5] Shiuchi T, Haque M S, Okamoto S, et al. Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system[J]. Cell Metab, 2009, 10(6):466-480. [6] Ayala J E, Bracy D P, Malabanan C, et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice[J]. J Vis Exp, 2011(57)pii:3188. [7] Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998,15(7):539-553. [8] 陈予东, 尹娜, 李昕, 等. 脑卒中患者血浆中α-突触核蛋白及其寡聚体形成量变化的研究[J]. 首都医科大学学报, 2013, 34(6):826-829. [9] Liu G, Chen M, Mi N, et al.Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains[J]. Neurobiol Aging, 2015, 36(9):2649-2659. [10] Galbo T, Olsen G S, Quistorff B, et al.Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism[J]. PLoS One, 2011, 6(11):e27424. [11] Højlund K, Poulsen M, Staehr P,et al. Effect of insulin on protein phosphatase 2A expression in muscle in type 2 diabetes[J]. Eur J Clin Invest, 2002, 32(12):918-923. [12] Dillin A, Hsu A L, Arantes-Oliveira N, et al. Rates of behavior and aging specified by mitochondrial function during development[J]. Science, 2002, 298(5602):2398-2401. [13] Lee S S, Lee R Y, Fraser A G, et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity[J]. Nat Genet, 2003, 33(1):40-48. [14] Short K R, Bigelow M L, Kahl J, et al. Decline in skeletal muscle mitochondrial function with aging in humans[J]. Proc Natl Acad Sci USA, 2005, 102(15):5618-5623. [15] Riera C E, Dillin A. Tipping the metabolic scales towards increased longevity in mammals[J]. Nat Cell Biol, 2015, 17(3):196-203. [16] Fujiwara H, Hasegawa M, Dohmae N,et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions[J]. Nat Cell Biol, 2002, 4(2):160-164. [17] Arawaka S, Wada M, Goto S,et al. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease[J]. J Neurosci, 2006, 26(36):9227-9238. [18] Kragh C L, Lund L B, Febbraro F, et al. Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells[J]. J Biol Chem, 2009, 284:10211-10222. |